Tonsil cancer (TC) is a type of malignant tumor that develops from tonsil tissue in the back of your throat and is a part of head and neck cancers [1]. Tonsils are organs of the immune system that help the body fight infection by stopping harmful bacteria from entering the body through the mouth. They are the body’s first line of defence against viruses and bacteria.
Tonsils are the most common source of oropharyngeal cancer, accounting for about 23.1% of malignant tumors in this anatomical region, with an overall incidence of 8.4 cases per 100,000 [1]. One of the main factors for tonsil cancer is the human papillomavirus, with up to 93% of new cases of oropharyngeal carcinoma being HPV positive (HPV+ TC) [2]. While smoking and alcohol remain important risk factors, the tonsil tumors now occur in younger individuals due to HPV infection related tumors.
Understanding risk factors and symptoms is key to preventing tonsil cancer. Early detection with no lymph node involvement, combined with innovative treatment options, can lead to a complete cure and improved outcomes.
Early Symptoms of Tonsil Cancer
Early-stage tonsil cancer can be challenging to detect because it can mimic symptoms of a common infection. The patient may notice a persistent sore throat, swollen lymph nodes, and difficulty swallowing [3].
Many cases of tonsil tumors are associated with HPV infection, which may not cause many symptoms at first, and one of the noticeable signs can be painless, enlarged lymph nodes on one side of the neck.
Stages and Classification of Tonsil Tumors
Tonsil cancer includes tumors that start in the tissue of the tonsils in the throat. Most tonsil carcinomas are squamous cell carcinomas, which means that they develop from squamous cells–the thin lining of the outer layer of the tonsil. When they are exposed to viruses, tobacco, alcohol, or other things that can cause uncontrolled growth due to mutation, they become cancerous cells.
The tonsil cancer stage is determined with the TNM classification [4]:
- Stage 1. The tumor is small, up to 2 cm, and has not spread.
- Stage 2. The cancer is more than 2 to 4 cm and doesn’t invade local lymph nodes.
- Stage 3. The tumor is more than 4 cm and has spread to one lymph node up to 3 cm on the same side.
- Stage 4. Indicates tumor growth into surrounding organs, such as the larynx, the muscle of the tongue, the medial pterygoid, and the hard palate, with possible spread to distal lymph nodes and formation of metastases.
Throat cancer can also be classified based on the presence or absence of human papillomavirus (HPV) with p-16 marker [5]:
- HPV-positive tonsil carcinomas (p16 positive) is less aggressive and has a better prognosis, with a 5-year survival rate for stage 1 that can be around 84%.
- HPV-negative tonsil cancer (p16 negative) can be more aggressive, with a 5-year survival rate for localized tumors of around 58%.
But survival rates can be influenced negatively in HPV-positive smokers, with the risk of progression or death increasing by 2% with each year of smoking [6]. Also, patients who continued smoking while receiving treatment had more than double the risk of a lethal outcome and increased the risk of developing a second primary tumor with about 1.5% per pack-year.
Diagnostic Methods for Tonsil Cancer
Oropharyngeal cancer is diagnosed with [1]:
- Endoscopy. It is a standard procedure to visualize the tumor with a thin tube camera that is passed down the throat and take biopsy samples to perform histological examination.
- HPV testing. The biopsy sample is being tested for human papillomavirus, particularly the p-16 marker, which can help determine prognosis and treatment planning.
- Computed tomography (CT scan). With the help of X-rays, it is used to evaluate the size and spread of the tumor to local or distant organs.
- PET-CT scan. It shows metabolically active cancer cells in the tumor location and at metastatic sites.
- MRI. Provides soft-tissue imaging that helps evaluate local cancer spread.
Treatment Options for Tonsil Cancer
The way tonsil cancer is treated depends on the stage it’s diagnosed at and HPV status. Some of the standard treatment options are [7]:
Surgery. Transoral Robotic Surgery (TORS) or Transoral Laser Microsurgery (TLM) for tonsil removal is the gold standard for the treatment of early throat cancer. Usually, not one tonsil is removed because of the small chance of bilateral synchronous tonsillar cancers. Side effects often include persistent difficulties swallowing, which can impact a patient's quality of life.
Radiation treatment. It is used to target cancer cells after the surgery or as a primary treatment on its own. It can be effective but has several side effects, like changes in taste, skin irritation, dry mouth, and non-healing mouth sores.
Chemotherapy. Uses drugs to destroy cancer cells and metastases, as well as healthy cells. That’s why it has a systemic effect on the whole body, causing severe vomiting, hair loss, low blood count, and hearing changes.
Immunotherapy. It is a new type of therapy added to protocols that includes checkpoint inhibitors and targeted drugs. It boosts the immune system to find cancer cells more efficiently. This therapy can be used before or after the surgery and paired with chemotherapy or radiation therapy to improve patients’ outcomes.
Innovative Therapies for Tonsil Cancer in Germany
Dendritic Cell Vaccination for Tonsil Cancer
Dendritic cell therapy is an advanced form of immunotherapy that aims to help the body's immune system recognize and destroy cancer cells, such as squamous cell carcinomas. Dendritic cells are the first detectors of something foreign in our bodies, and they teach T-cells how to detect the threat. This groundbreaking discovery was awarded the Nobel Prize in Physiology or Medicine in 2011 to Ralph M. Steinman, explaining the role of dendritic cells in our immunity [8].
To create this personalised vaccine, some blood is taken from the patient, and the dendritic cells are further isolated in the laboratory and taught to recognise the patient's own cancer antigens. Then the "trained" dendritic cells are injected back into the patient, where they begin stimulating T-cells to target not only cancerous cells in the primary tumor but also those in the lymph nodes and metastases.
This makes a dendritic cell vaccination a highly personalized target therapy that enables efficient treatment for tonsil cancer in both early-stage and advanced tumors.
In the interview with Professor Gansauge, you will find more exclusive information on Dendritic cell therapy and how this treatment can be used for your specific needs. He talks in detail on how the therapy works and explain all the details about long lasting immunity it provides.
Interview with Professor Frank Gansauge on Dendritic Cell Therapy
Regional chemotherapy for Tonsil Cancer
Regional chemotherapy is a new way of elevating standard chemo and cutting out all those serious side effects that it can lead to. By delivering medication directly to the tumor blood supply, higher concentrations can be achieved, thereby reducing overall toxicity.
As a part of regional chemotherapy, Isolated thoracic perfusion and chemofiltration can be performed as a treatment option for head and neck cancer [9]. High-dose chemotherapy is delivered through common carotid artery catheters. This gives access to the head and neck arteries, allowing the drug to reach the tonsil cancer site more quickly and efficiently. Then, a chemofiltration-filtration of the blood is performed to remove an access drug and protect organs like the liver or kidneys. This gives the patient a chance to eradicate side effects that standard treatment can cause and to lower the tumor burden more effectively, achieving cancer control in both advanced and early stages.
Another way of performing regional chemotherapy is intra-arterial chemotherapy via an implantable system. A special port is implanted in the direct artery that feeds the tumor. Through that port, several cycles of chemotherapy can be delivered with further chemofiltration to lower systemic toxicity. This allows the elimination of side effects such as neuro-, oto-, and renal toxicity, improving patients’ quality of life and giving them meaningful years of life.
Prof. Karl R. Aigner and colleagues at Medias Klinikum Burghausen pioneered in intra-arterial chemotherapy in Germany in patients with tonsil cancer. The study applied 1 to 7 cycles of regional chemotherapy for tonsil tumors to 11 patients with no prior treatment, showing remarkable results: 63,6% achieved a complete response, 27,3% stabilized the disease with partial response [10]. Median overall survival reached 27 months–much longer than after standard treatment approaches.
This and other studies have documented significant improvements in progression-free time and overall survival rates using intra-arterial chemotherapy as a part of regional chemotherapy treatment, making it an excellent choice for patients with advanced throat cancer and those in the early stages who refuse surgery.
| Duration | Side Effects | Indications | Survival rate | |
|---|---|---|---|---|
| Regional chemotherapy | Multiple sessions (up to 4) | Mild (localized discomfort) | Primary inoperable methods and metastases all types of malignant tumors | ~80% for advanced cancer |
| Standard chemotherapy | Several cycles, sometimes for month | Severe (nausea, hair loss) | Malignant tumors of all stages | ~20% for advanced cancer |
*Booking Health data
Why Choose Treatment of Tonsil Cancer Abroad?
For many patients and their families, cancer treatment can be overwhelming and scary. With so many opinions from medical oncologists or other medical specialists, it’s easy to get lost and lose hope in a cure. One of the most difficult things can be choosing the right hospital and medical team for your treatment. The quality of cancer care differs significantly, and selecting the right clinic can influence your outcomes.
Leading hospitals abroad, particularly in Germany, are one of the top destinations for treatment, no matter the cancer's stage or type. They offer precise diagnostic techniques, state-of-the-art new treatments, as well as special care with support every step of the way. Here in Germany, patients have access to minimally invasive and organ-preserving surgical approaches, as well as targeted therapy and immunotherapy.
They will carefully examine your medical history and perform any necessary diagnostic tests, such as PET-CT or HPV testing, if needed for further cancer treatment. Then, with the help of a multidisciplinary team, they will create a personal treatment plan aimed at controlling tumor symptoms, preserving quality of life, and achieving complete remission.
Another benefit of choosing a clinic in Germany for oropharyngeal cancer is experience. All of Germany’s cancer hospitals are scientific centers of research and innovation, making them known for high survival rates, lower complications, and attention to every detail in your healing journey.
| Treatment methods | Germany | USA | Great Britain | Australia |
|---|---|---|---|---|
| Surgery | €25,000 - €45,000 | €65,000 - €85,000 | €35,000 - €55,000 | €30 000 - €50 000 |
| Chemotherapy | full course €80,000 - €150,000 | full course €100,000 - €180,000 | full course €90,000 - €165,000 | full course €50,000 - €200 000 |
| Dendritic cell therapy | €20,000 - €38,000 | €100,000 - €150,000 | Not available | Not available |
*Prices may vary depending on the course of treatment and tumor characteristics
Patient story
An advanced tonsil carcinoma in the oral cavity can seem like an end-of-life diagnosis and become an excuse to give up on happiness. For a lot of patients, standard treatment options like surgery, radiation therapy, and chemotherapy may threaten losing speech, the ability to swallow, or even their whole identity and career path. These heavy side effects can stand between the patient’s health and their ability to receive care and achieve remission.
The patient in this story is a 60-year-old saxophonist who was told he has stage 4 advanced tonsil carcinoma with lymph node metastases on both sides of the neck [11]. He was advised to undergo aggressive surgical treatment that would make it impossible to play on his musical instrument, and he was about to lose his career. He and his family reached out for help to one of Germany’s top hospitals for head and neck cancer and were offered to undergo a life-changing cancer care– an isolated thoracic perfusion with chemofiltration. After a single procedure CT-scan showed an impressive tumor shrinkage. He continued the regional therapy for three additional cycles, and his tumor continued to respond. After 7 months, he went into complete remission and has been now for almost 10 years. The patient and his family were amazed not only by the results but with how attentive and supportive the medical team was, making it the best experience possible. Now, he continues to play on his saxophone and lives an active life. This treatment also gave him the possibility to avoid needing a tracheostomy or feeding tube.
This case shows that in some patients, even with a stage 4 cancer diagnosis, when standard therapy can do more harm than good, methods like an isolated thoracic perfusion with chemofiltration can provide significant tumor control. Regional chemotherapy helps target the malignancy more intensively while preserving healthy cells and minimizing side effects, which is important in head and neck cancers, where function and appearance significantly impact daily life.
A Medical Journey: Every Step of the Way With Booking Health
Finding the best treatment strategy for your clinical situation is a challenging task. Being already exhausted from multiple treatment sessions, having consulted numerous specialists, and having tried various therapeutic interventions, you may be lost in all the information given by the doctors. In such a situation, it is easy to choose a first-hand option or to follow standardized therapeutic protocols with a long list of adverse effects instead of selecting highly specialized innovative treatment options.
To make an informed choice and get a personalized cancer management plan, which will be tailored to your specific clinical situation, consult medical experts at Booking Health. Being at the forefront of offering the latest medical innovations for already 12 years, Booking Health possesses solid expertise in creating complex cancer management programs in each case. As a reputable company, Booking Health offers personalized tonsil cancer treatment plans with direct clinic booking and full support at every stage, from organizational processes to assistance during treatment. We provide:
- Assessment and analysis of medical reports
- Development of the medical care program
- Selection of a suitable treatment location
- Preparation of medical documents and forwarding to a suitable clinic
- Preparatory consultations with clinicians for the development of medical care programs
- Expert advice during the hospital stay
- Follow-up care after the patient returns to their native country after completing the medical care program
- Taking care of formalities as part of the preparation for the medical care program
- Coordination and organization of the patient's stay in a foreign country
- Assistance with visas and tickets.
- A personal coordinator and interpreter with 24/7 support
- Transparent budgeting with no hidden costs
Health is an invaluable aspect of our lives. Delegating management of something so fragile yet precious should be done only to experts with proven experience and a reputation. Booking Health is a trustworthy partner who assists you on the way of pursuing stronger health and a better quality of life. Contact our medical consultant to learn more about the possibilities of personalized treatment with innovative methods for tonsil cancer with leading specialists in this field.
Hope in Cancer Treatment: Patient Success with Booking Health
Frequently Asked Questions About Tonsil Cancer
Send request for treatmentSymptoms of tonsil cancer may resemble a common throat infection at early stages. Patients experience throat pain, difficulty swallowing, and irritation. Later, swollen lymph nodes can be visible on the neck. But HPV-related tonsil cancer may show fewer initial symptoms, making early diagnosis challenging.
When diagnosed in the early stages, tonsil cancer is treatable, especially using a combination of innovative methods like regional chemotherapy.
Life expectancy depends on the stage of the carcinoma and the presence of metastases.
Early symptoms of tonsil cancer include swollen tonsils and a persistent sore throat. Later, difficulties swallowing, ear pain, and a lump in the neck can occur.
A cure for tonsil cancer is possible in the early stages. Patients can achieve long-term remission with a combined approach and personalized treatment.
The last stage of tonsil cancer progression is stage 4c, when the tumor not only invades local organs and lymph nodes, but also has distant metastasis in organs like lungs, liver, or bones.
Yes, you can achieve treatment success with a multimodal approach that includes surgery, radiotherapy, and innovative treatments such as regional chemotherapy.
The survival rate for early HPV-positive tonsil tumors is around 80-90% and for HPV-negative cancers, it is closer to 40-50%.
Best treatment options for tonsil cancer depend on your stage and type of cancer, but often tonsil cancer treated with innovative treatment methods like dendritic cell therapy or regional chemotherapy with fewer side effects and a better response, giving a patient a chance to keep their quality of life even when the disease is advanced.
Human papillomavirus has become the main cause of tonsil tumors in recent years. HPV-positive tumors usually have a better prognosis and response to treatment.
Stage 4 tonsil cancer survival rates are around 30-40%. But even if you have advanced cancer with innovative personalized treatment, you can achieve a 5-year survival rate of nearly 65%.
Immunotherapy for tonsil cancer, including checkpoint inhibitors, is one of the possible ways of treatment. This type of treatment helps the immune system to recognise and attack cancer cells. Dendritic cell therapy is also a new type of immunotherapy that helps achieve lifelong immunity against tonsil carcinoma.
Choose treatment abroad and you will for sure get the best results!
Authors:
This article was edited by medical experts, board-certified doctors Dr. Nadezhda Ivanisova, and Dr. Yana Dmytryshyn. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!
Our editorial policy, which details our commitment to accuracy and transparency, is available here. Click this link to review our policies.
Sources:
[1] Andrew J. Williamson; Sanjana Mullangi; Ajeet Gajra. Tonsil Cancer. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan. 2023 Sep 4. [NCBI]
[2] Aimée R. Kreimer, Anil K. Chaturvedi, Laia Alemany, et al. Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI. Oral Oncology Vol. 108, September 2020, 104736. [DOI]
[3] Teresa V Chan. The Patient with Sore Throat. Med Clin North Am. 2010 Aug 22;94(5):923–943. doi: 10.1016/j.mcna.2010.06.001. [DOI] [PMC free article]
[4] Rengaswamy Sankaranarayanan, Kunnambath Ramadas, Hemantha Amarasinghe, Sujha Subramanian, and Newell Johnson. Oral Cancer: Prevention, Early Detection, and Treatment. In: Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov 1. Chapter 5. doi: 10.1596/978-1-4648-0349-9_ch5. [DOI] [NCBI]
[5] Jia Wang, Xiaolin Li, Dongdong Niu et al. Mortality patterns of patients with tonsillar squamous cell carcinoma: a population-based study. Front Endocrinol (Lausanne). 2023 Dec 7;14:1158593. doi: 10.3389/fendo.2023.1158593. [DOI] [PMC free article]
[6] Maura L Gillison, Qiang Zhang, Richard Jordan et al. Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer. J Clin Oncol. 2012 May 7;30(17):2102–2111. doi: 10.1200/JCO.2011.38.4099. [DOI] [PMC free article]
[7] Evan J Patel, Angela W Zhu, Jamie R Oliver et al. Treatment of Early Stage Tonsil Cancer in the Age of Human Papillomavirus-Associated Malignancies. Otolaryngol Head Neck Surg. 2021 Jul;165(1):104-112. doi: 10.1177/0194599820973256. Epub 2020 Dec 8. [DOI] [PubMed]
[8] Ralph M Steinman. Dendritic cells: understanding immunogenicity. Eur J Immunol. 2007 Nov:37 Suppl 1:S53-60. doi: 10.1002/eji.200737400. [DOI] [PubMed]
[9] Karl R Aigner, Emir Selak, Kornelia Aigner. Short-term intra-arterial infusion chemotherapy for head and neck cancer patients maintaining quality of life. J Cancer Res Clin Oncol. 2019 Jan;145(1):261-268. doi: 10.1007/s00432-018-2784-4. Epub 2018 Oct 31. [DOI] [PubMed]
[10] Karl Reinhard Aigner, Sabine Gailhofer, Kornelia Aigner. Carotid artery infusion via implantable catheters for squamous cell carcinoma of the tonsils. World J Surg Oncol. 2018 Jun 5;16:104. doi: 10.1186/s12957-018-1404-8. [DOI] [PMC free article]
[11] Karl R Aigner, Emir Selak, Kornelia Aigner. Approaching 10 years disease-free survival after isolated thoracic perfusion for advanced stage IV tonsil carcinoma: A case report. Int J Surg Case Rep. 2020:75:71-74. doi: 10.1016/j.ijscr.2020.08.058. Epub 2020 Sep 3. [DOI] [PubMed]
Read:
New Effective Treatments for Stage 4 Cancer: Innovations in Oncology
Не знаете, с чего начать?
Свяжитесь с Booking Health
